Kansas City Center for Anxiety Treatment, P.A.
Overland Park, Kansas, 66212, United States
NCT Number: NCT03269370
Anxiety disorders are among the most common psychological disorders, with prevalent onset in childhood and adolescence. While cognitive behavioral therapy (CBT) is considered the first-line treatment for pediatric anxiety, significant barriers remain in accessing CBT and other evidence-based treatments (EBTs), and credible self-help resources based in EBT concepts. This study evaluates a family-guided CBT game application (Anchors App), targeted to children ages 6-11 and their families, which focuses on delivering adaptive CBT-based coping skills to those who have sub-clinical to mild anxiety and related symptoms in a convenient and portable platform. Anchors App will be evaluated in two forms (standard and "parent-enhanced") in comparison to use of a self-help book or waitlist control. The rapid advancements in technology allows richer interactive capacity, content scalability, customizability, and subscription to a broader range of content, which this app capitalizes on in order to increase access to CBT skill concepts directly to pediatric stakeholder populations. If found to be effective, Anchors App has the opportunity to promote engagement of EBT concepts in every-day use through smartphone technology, and will change the landscape of mental health prevention and early intervention for children and families.
Looking for future studies?
Notify Me6 year–11 year
All sexes
Interventional
Not applicable
Overland Park, Kansas, 66212, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Modular Cognitive Behavioral Therapy delivered through a mobile app.
Modular Cognitive Behavioral Therapy delivered through a mobile app. Extra modules will focus specifically on parenting skills relevant to having an anxious child.
Parents will read "Helping Your Anxious Child: A Step-by-Step Guide" (Rapee, Wignall, Spence, Lyneham, & Cobham, 2008)
Time frame: Entry into study, 6 weeks, 12 weeks
Parent and child report of anxiety with 6 DSM-IV criteria sub scales. Measuring change in reported anxiety levels in these 6 different domains over time.
Time frame: Entry into study, 6 weeks, 12 weeks
A screener for overall psychological distress of parent with sub scales assessing anxiety, depression, and stress.
Time frame: Entry into study, 6 weeks, 12 weeks
A 20-item screener for childhood depression and psychological distress
Time frame: Entry into study, 6 weeks, 12 weeks
A measure of parent anxiety sensitivity (fear of arousal-related sensations) in physical, social, and cognitive domains
Time frame: Entry into study, 6 weeks, 12 weeks
A measure of sensitivity to symptoms of anxiety, similar to the ASI, measuring physical, social, and mental incapacitation concerns in children.
Time frame: Entry into study, 6 weeks, 12 weeks
A parent-report measure of child behavioral inhibition, which has been determined to be a risk factor for later psychopathology, particularly anxiety.
Time frame: Entry into study, 3 weeks, 6 weeks, 12 weeks
Self-report measure to ensure the child is not receiving outside interventions (as would disqualify them from study) and to gauge parents' confidence in managing child's symptoms
Time frame: 6 weeks
Self-report measure to gauge families' thoughts on user-friendliness, perceived effectiveness of intervention, and likelihood to use again or recommend to others
Kansas City Center for Anxiety Treatment, P.A.
Industry
Randomized Controlled Trial of a Family-focused CBT Skills App and Standard Self Help Options for Childhood Anxiety and Related Conditions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT03821779
Anxiety, Anxiety Disorders
Bordeaux, France
View Trial DetailsNCT06981000
Anxiety, Anxiety Disorders
Copenhagen, Denmark
View Trial DetailsNCT06502483
Anxiety, Anxiety Disorders
Brighton, Massachusetts, United States
View Trial Details